September quarter revenue rises, but profit and margins fall
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 14.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved unaudited September 2026 results. Standalone revenue rose 6.4% year on year to Rs 193.39 crore, but profit fell 36.8% to Rs 23.29 crore. Consolidated revenue rose 16.5% to Rs 211.64 crore, while profit fell 23.4% to Rs 28.22 crore. The prior-year quarter included Rs 11.22 crore of exceptional insurance income. Before interest, tax and depreciation, the consolidated six-month margin narrowed from 23.4% to 22.2%.
Revenue growth supports expansion, but lower profit and narrower margins may weigh on sentiment. New acquisitions also make comparisons less clear.